CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 94 enrolled
Drug / intervention
screening questionnairebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01004952
NCT01004952N/ACompleted
CompareCT.gov

Measuring Real Time Decision-Making About UVR Protection

Memorial Sloan Kettering Cancer Center·observational·Posted Oct 30, 2009·Updated Jan 7, 2026

In Brief

An observational study evaluating screening questionnaire for Melanoma. Completed, enrolled 94 participants across 1 site.

Detailed Summary

The purpose of this study is to understand how people make decisions about sun protection. This study is important in helping to protect against sun exposure, since it is a main risk factor for melanoma. The investigators would like to understand the decisions people make about sun protection so that they can improve their ability to help individuals who may be at risk for melanoma.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMelanoma
CountriesUnited States
CollaboratorsUniversity of British Columbia, San Diego State University, Stony Brook University

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 30, 2009
Enrollment StartOct 27, 2009
Primary CompletionSep 6, 2024
TodayJul 2, 2026
Enrollment to primary: 14.9 yearsPosted 16.7 years ago

Interventions

screening questionnairebehavioral

Phase I involves in-home interviews of 25 participants to understand the factors that affect participants' decision-making about UVR protection (sunscreen use, shade-seeking, hat use, use of protective clothing). In Phase II, we plan to recruit a sample of 60 melanoma first degree relatives (FDRs) and use an electronic narrative diary to record their daily behaviors about UVR protection. They will be asked to carry a interactive voice response (IVR) system for 14 days and they should be in the continental United States.